Trial · NCT02163447
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Prevalence of Placental Malaria | Delivery | Only women who delivered and had histopathology results were analyzed. 2 women in 3 Dose SP and 1 woman in monthly DP arms completed the study but did not have histopathology results. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Incidence of Malaria in Pregnant Women | Time at risk will begin after first dose of study drug and will end when study participants deliver or early study termination | events per person years | NUMBER | |
| PRIMARY | Incidence of Malaria in Infants | Time at risk will begin at birth and will end when study participants reaches 24 months of age or early study termination (if prior to 24 months of age) | All live births | Events per person years | NUMBER |
| PRIMARY | Incidence of Malaria in Infants | Time at risk will begin at 24 months of age and will end when study participants reaches 36 months of age or termination | All live births | Events per person years | NUMBER |
| SECONDARY | Number of Participants With Blood Samples Positive for Parasites by Microscopy or LAMP | Delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Maternal Blood Samples Positive for Parasites by Microscopy and LAMP at Delivery | At delivery | One observation in the monthly DP arm did not have results for microscopy; this outcome measure tests blood taken from the mother's arm (different from outcome measure 4 which tests blood taken from the placenta) | participants | NUMBER |
| SECONDARY | Number of Participants With One or More Birth Outcomes: Congenital Malformations, Spontaneous Abortion, LBW (<2500g), Still Birth, Pre-term Delivery | Delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Prevalence of Anemia in Pregnant Women | After first dose of study drugs up to delivery or early termination | hemoglobin measurements taken every 12wk | NUMBER | |
| SECONDARY | Incidence of Complicated Malaria in Infants | Birth up to 24 months of age or early study termination | All live births | Events per person years | NUMBER |
| SECONDARY | Incidence of Hospital Admissions in Infants | Birth up to 24 months of age or early study termination | Events per person years | NUMBER | |
| SECONDARY | Prevalence of Gametocytemia in Pregnant Women | Gestational age between 12-20 weeks (at study entry) up to delivery | Positive blood smears | NUMBER | |
| SECONDARY | Prevalence of Parasitemia in Infants | Birth up to 24 months of age or early study termination | Positive blood smears | NUMBER | |
| SECONDARY | Prevalence of Parasitemia at the Time of Monthly Routine Visits During Pregnancy | After first dose of study drug through delivery or early termination | Positive specimens | NUMBER | |
| SECONDARY | Prevalence of Gametocytemia in Infants | Birth up to 24 months of age or early study termination | Positive blood smears | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02163447/outcomes